Structure Therapeutics Inc
GPCR16.780USD
-0.810-4.60%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
16.780USD+16.780After-hours (ET)
2.90BMarket Cap
LossP/E TTM
Structure Therapeutics Inc
16.780
-0.810-4.60%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q2
FY2022Q1
FY2021Q4
Operating expenses
75.89%56.31M
51.84%47.06M
75.31%45.84M
28.20%33.32M
62.93%32.02M
139.23%30.99M
--26.14M
86.15%25.99M
51.71%19.65M
-2.40%12.96M
--13.96M
--12.95M
--13.27M
R&D expenses
107.30%42.87M
67.08%33.49M
86.11%32.60M
13.60%22.05M
57.43%20.68M
139.74%20.04M
--17.52M
90.66%19.41M
54.67%13.13M
-15.62%8.36M
--10.18M
--8.49M
--9.91M
Depreciation, depletion, and amortization
23.42%274.00K
279.17%273.00K
235.44%265.00K
213.51%232.00K
217.14%222.00K
0.00%72.00K
--79.00K
25.42%74.00K
0.00%70.00K
9.09%72.00K
--59.00K
--70.00K
--66.00K
Operating profit
-75.89%-56.31M
-51.84%-47.06M
-75.31%-45.84M
-28.20%-33.32M
-62.93%-32.02M
-139.23%-30.99M
---26.14M
-86.15%-25.99M
-51.71%-19.65M
2.40%-12.96M
---13.96M
---12.95M
---13.27M
Net non-operating interest income (expenses)
Income before tax
-79.70%-46.73M
-46.46%-36.34M
-44.46%-33.88M
-12.17%-25.98M
-44.89%-26.01M
-105.85%-24.82M
---23.46M
-66.83%-23.16M
-37.85%-17.95M
9.19%-12.05M
---13.88M
---13.02M
---13.28M
Income tax
237.93%98.00K
143.59%136.00K
-77.28%92.00K
-55.08%53.00K
16.00%29.00K
-73.33%-312.00K
--405.00K
84.38%118.00K
-58.33%25.00K
-322.22%-180.00K
--64.00K
--60.00K
--81.00K
Income after tax
-79.88%-46.83M
-48.88%-36.48M
-42.39%-33.98M
-11.83%-26.03M
-44.85%-26.04M
-106.34%-24.50M
---23.86M
-66.91%-23.28M
-37.41%-17.98M
11.09%-11.88M
---13.95M
---13.08M
---13.36M
Net income from continuous operations
-79.88%-46.83M
-48.88%-36.48M
-42.39%-33.98M
-11.83%-26.03M
-44.85%-26.04M
-106.34%-24.50M
---23.86M
-66.91%-23.28M
-37.41%-17.98M
11.09%-11.88M
---13.95M
---13.08M
---13.36M
Net income attributable to controlling interests
-79.88%-46.83M
-48.88%-36.48M
-42.39%-33.98M
-11.83%-26.03M
-44.85%-26.04M
-106.34%-24.50M
---23.86M
-50.55%-23.28M
-37.41%-17.98M
23.04%-11.88M
---15.46M
---13.08M
---15.43M
Preferred share dividend
----
----
----
----
----
--0.00
--0.00
----
----
-100.00%0.00
--1.52M
----
--115.00K
Net income attributable to common shareholders
-79.88%-46.83M
-48.88%-36.48M
-42.39%-33.98M
-11.83%-26.03M
-44.85%-26.04M
-106.34%-24.50M
---23.86M
-50.55%-23.28M
-37.41%-17.98M
23.04%-11.88M
---15.46M
---13.08M
---15.43M
Basic earnings per share
-46.06%-0.27
-20.34%-0.21
4.63%-0.20
13.43%-0.18
25.71%-0.19
-62.99%-0.18
---0.21
-44.01%-0.20
-110.50%-0.25
23.03%-0.11
---0.14
---0.12
---0.14
Diluted earnings per share
-46.06%-0.27
-20.34%-0.21
4.63%-0.20
13.43%-0.18
25.71%-0.19
-62.99%-0.18
---0.21
-44.01%-0.20
-110.50%-0.25
23.03%-0.11
---0.14
---0.12
---0.14
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
